Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials

Autor: CS Tam, P Kapoor, JJ Castillo, C Buske, SM Ansell, AR Branagan, E Kimby, Y Li, ML Palomba, L Qiu, M Shadman, JP Abeykoon, S Sarosiek, JMI Vos, S Yi, D Stephens, D Roos-Weil, AM Roccaro, P Morel, NC Munshi, KC Anderson, J San-Miguel, R Garcia-Sanz, MA Dimopoulos, SP Treon, MJ Kersten

Publikováno v: Seminars in hematology. W.B. Saunders Ltd

Recent advances in the understanding of Waldenström macroglobulinemia (WM) biology have impacted the development of effective novel agents and improved our knowledge of how the genomic background of WM may influence selection of therapy. Consensus P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd28c3ec94eeea574952c74fd4e7892
https://pure.amc.nl/en/publications/report-of-consensus-panel-7-from-the-11th-international-workshop-on-waldenstroem-macroglobulinemia-on-priorities-for-novel-clinical-trials(586d4da0-fcb8-439c-9b02-c5a8501d9eeb).html

A multi-glycomic platform for the analysis of food carbohydrates.

Autor: Couture G; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Cheang SE; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Suarez C; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Chen Y; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Bacalzo NP Jr; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Jiang J; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Weng CC; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Stacy A; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Castillo JJ; Department of Chemistry, University of California, Davis, Davis, CA, USA.; Foods for Health Institute, University of California, Davis, Davis, CA, USA., Delannoy-Bruno O; Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St Louis, MO, USA., Webber DM; Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Barratt MJ; Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Gordon JI; Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis, MO, USA.; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Mills DA; Foods for Health Institute, University of California, Davis, Davis, CA, USA.; Department of Food Science and Technology, University of California, Davis, Davis, CA, USA.; Department of Viticulture and Enology, University of California, Davis, Davis, CA, USA., German JB; Foods for Health Institute, University of California, Davis, Davis, CA, USA.; Department of Food Science and Technology, University of California, Davis, Davis, CA, USA., Fukagawa NK; USDA Agricultural Research Service, Beltsville Human Nutrition Research Center, Beltsville, MD, USA., Lebrilla CB; Department of Chemistry, University of California, Davis, Davis, CA, USA. cblebrilla@ucdavis.edu.; Foods for Health Institute, University of California, Davis, Davis, CA, USA. cblebrilla@ucdavis.edu.; Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA. cblebrilla@ucdavis.edu.

Publikováno v: Nature protocols [Nat Protoc] 2024 Nov; Vol. 19 (11), pp. 3321-3359. Date of Electronic Publication: 2024 Jul 18.

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs.

Autor: Gharib SA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.; Computational Medicine Core at Center for Lung Biology, University of Washington, Seattle, Washington, USA., Vemireddy R; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA., Castillo JJ; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.; Research and Development Service, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA., Fountaine BS; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA., Bammler TK; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA., MacDonald JW; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA., Hull-Meichle RL; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.; Research and Development Service, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.; Alberta Diabetes Institute, Department of Cell Biology, University of Alberta, Edmonton, AB, Canada., Zraika S; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA. zraikas@uw.edu.; Research and Development Service, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA. zraikas@uw.edu.; Veterans Affairs Puget Sound Health Care System, 1660 South Columbian Way (151), Seattle, WA, 98108, USA. zraikas@uw.edu.

Publikováno v: Scientific reports [Sci Rep] 2024 Oct 28; Vol. 14 (1), pp. 25689. Date of Electronic Publication: 2024 Oct 28.

ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells.

Autor: Munshi M; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Liu X; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Kofides A; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Tsakmaklis N; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Hunter ZR; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Guerrera ML; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Canning A; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Gustine JN; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Boston University Medical Center, Boston, Massachusetts, USA., Liu S; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Hatcher JM; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Chen J; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Boston University Medical Center, Boston, Massachusetts, USA., Meid K; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Sarosiek S; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Flynn CA; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Branagan AR; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., von Keudell G; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Palomba LM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Castillo JJ; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Yang G; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Treon SP; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.

Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy.

Autor: Cabrera ME; Hospital del Salvador, Universidad de Chile, Santiago, Chile., Peña C; Hospital del Salvador, Providencia, Chile., Vega V; Hospital San Juan de Dios, Santiago, Chile., Rojas H; Hospital Sótero del Río, Santiago, Chile., Pizarro A; Hospital San Borja Arriarán, Santiago, Chile., Rojas C; Hospital Gustavo Fricke, Valparaíso, Chile., Calderon S; Hospital Regional de Valdivia, Valdivia, Chile., Oliva J; Hospital Las Higueras de Talcahuano, Talcahuano, Chile., Hales C; Hospital Juan Noé, Arica, Chile., Rojas B; Hospital Carlos van Buren, Valparaíso, Chile., Intriago M; Hospital Regional de La Serena, La Serena, Chile., Capurro M; Hospital Dr. Hernan Henriquez Aravena, Temuco, Chile., Gonzalez ML; Hospital Regional de Osorno, Osorno, Chile., Castillo JJ; Division of Hematological Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Sep; Vol. 7 (9), pp. e2126.